Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Urologic Oncology|May 18, 2023
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world populationBraden Millan, Rodney H Breau, Ranjeeta Mallick, et al.Urologic Oncology|January 14, 2014
Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaborationBassel G Bachir, Armen G Aprikian, Jonathan I Izawa, et al.BMC Urology|September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validationVéronique Ouellet, Armen Aprikian, Alain Bergeron, et al.The Prostate|September 3, 2015
DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrenceAaron M Horning, Julius A Awe, Chiou-Miin Wang, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 8, 2018
Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trialsPierre I Karakiewicz, Emanuele Zaffuto, Anil Kapoor, et al.Urologic Oncology|January 10, 2017
Quality indicators in the management of bladder cancer: A modified Delphi studySatya R Khare, Armen Aprikian, Peter Black, et al.Future Oncology (London, England)|June 19, 2026
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadirMichael Ong, Christopher Morash, Robert J Hamilton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2025
Metformin Active Surveillance Trial in Low-Risk Prostate CancerNeil E Fleshner, Rui M Bernardino, Jonathan Izawa, et al.Pageof 5